Zentralinstitut für seelische Gesundheit
Mannheim 68159
2 studies enrolling now · 11 studies all time
What they study most
Alcohol Use Disorder, Alzheimer Disease, Borderline Personality Disorder, Depressive Disorder, Major, Post-Traumatic Stress Disorder, Schizophrenia
Studies at this site
- A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder — Recruiting now
- A Study of Brenipatide in Participants With Alcohol Use Disorder — Recruiting now
- A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study — Stopped early
- Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1) — Completed
- A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD) — Running, not enrolling
- A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression — Completed
- A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder — Completed
- A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder — Completed
- Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia — Completed
- Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo — Completed
- BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. — Completed